Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
EP1.16 - Treatment in the Real World - Support, Survivorship, Systems Research
- 08:00 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: E-Poster Viewing in the Exhibit Hall
- Track: Treatment in the Real World - Support, Survivorship, Systems Research
-
+
EP1.16-04 - Real World Clinical Outcomes for Metastatic Non-Small Cell Lung Cancer (mNSCLC) at IRST Italy
08:00 - 08:00 | Presenter: Angelo Delmonte | Author(s): Mattia Altini, Ilaria Massa, William Balzi, Nicola Gentili, Flavia Foca, Valentina Danesi, Silvia Manunta, FLAVIA Ejzykowicz, Sheenu Chandwani, Marco Angelo Burgio, Paola Cravero, alberto Verlicchi, Giuseppe Bronte, Lucio Crino
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P1.01-59 - Expanding Access to Large-Scale Genomic Mutational Analyses for Patients with Advanced NSCLC in Italy
09:45 - 09:45 | Presenter: Vanesa Gregorc | Author(s): Chiara Lazzari, Alessandro Guida, Gabriele Bucci, Paolo Graziano, Maria Giulia Cangi, Gianmaria Frigè, Antonio Rossi, Arnaud Ceol, Davide Sardina, Michele Milella, Matteo Pallocca, Paolo Vigneri, Laura Fancello, Simonetta Buglioni, Gianmarco Motta, Tommaso Biagini, Erika Rijavec, Silvia Bonfiglio, Angelo Delmonte, Luca Toschi, Giuseppe Banna, Domenico Galetta, Alessandra Bearz, Alfredo Tartarone, Francesco Verderame, Mariagrazia Daidone, Maurizio Fanciulli, Gennaro Ciliberto, Pier Giuseppe Pelicci, Ruggero De Maria, Luca Mazzarella
- Abstract
Loading...
-
+
P1.14 - Targeted Therapy
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
-
+
P1.14-03 - Molecular Determinants for Lorlatinib Activity in ROS1 Positive NSCLC: Results of the Prospective PFROST Trial
09:45 - 09:45 | Presenter: Lorenza Landi | Author(s): marcello Tiseo, Lukas C Heukamp, Roopika Menon, Gianluca Spitaleri, Diego Luigi Cortinovis, Angelo Delmonte, Domenico Galetta, Manolo D'Arcangelo, Federica D'Incà, Miriam Bertrand, Balázs Jóri, Angela Zacher, Cesare Gridelli, Silvia Novello, Rita Chiari, Claudio Verusio, Lucio Crino, Federico Cappuzzo
- Abstract
Loading... -
+
P1.14-05 - TP53 Exon 8 Mutation and Prognosis in EGFR-Mutated NSCLC Patients Treated with First-And-Second-Generation TKIs
09:45 - 09:45 | Presenter: Paola Ulivi | Author(s): Matteo Canale, Elisabetta Petracci, Lucio Crino, Nicoletta De Luigi, Vienna Ludovini, Alessandra Dubini, Sara Baglivo, Elisa Minenza, Elisa Chiadini, Lorenza Landi, Maximilian Papi, Angelo Delmonte, Giuseppe Bronte
- Abstract
Loading...
-
+
P2.01 - Advanced NSCLC
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P2.01-15 - Phase II Single Arm Study of CABozantinib in Non-Small Cell Lung Cancer Patients with MET Deregulation (CABinMET)
10:15 - 10:15 | Presenter: Manolo D'Arcangelo | Author(s): Davide Tassinari, Filippo De Marinis, Angelo Delmonte, Domenico Galetta, Fabiana Letizia Cecere, Sara Pilotto, francesca Zanelli, Laura Bonanno, Lorenza Landi, Federica D'Incà, Federico Cappuzzo
- Abstract
Loading...
-
+
P2.04 - Immuno-oncology
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P2.04-49 - Nivolumab Plus Ipilimumab (NI) Versus Chemotherapy Plus Nivolumab (CN) in Squamous Cell Lung Cancer (SqCLC): The SQUINT Trial
10:15 - 10:15 | Presenter: Lorenza Landi | Author(s): Laura Bonanno, Angelo Delmonte, Maximilian Papi, Valeria Stati, Vincenzo Minotti, Chiara Bennati, Federica D'Incà, Maria Rita Migliorino, Stefani Gori, Antonio Santo, Francovito Piantedosi, Antonio Russo, Federico Cappuzzo
- Abstract
Loading... -
+
P2.04-84 - NSCLC Survival Expectancy for Patients Treated with Docetaxel/Nintedanib in the SENECA Trial and Previous Immunotherapy
10:15 - 10:15 | Presenter: Enrica Capelletto | Author(s): Giorgia Osman, Alessandro Morabito, Rita Chiari, Francesco Grossi, marcello Tiseo, Francesco Di Costanzo, Angelo Delmonte, Gianpiero Romano, Andrea Misino, Vieri Scotti, Vanesa Gregorc, Salvatore Pisconti, Maria Bonomi, Alessandro Del Conte, Libero Ciuffreda, Ida Colantonio, Emilio Bria, Serena Ricciardi, Anna Manzo, Giulio Metro, Anna Maria Morelli, Rossana Critelli, Ilaria Stura, Giuseppe Migliaretti, Silvia Novello
- Abstract
Loading...